X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21995) 21995
Book / eBook (115) 115
Book Chapter (76) 76
Magazine Article (33) 33
Newsletter (28) 28
Dissertation (4) 4
Reference (4) 4
Conference Proceeding (3) 3
Newspaper Article (3) 3
Book Review (2) 2
Publication (2) 2
Data Set (1) 1
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17522) 17522
female (8717) 8717
male (7773) 7773
immunology (6914) 6914
animals (6525) 6525
adult (5274) 5274
middle aged (4956) 4956
immunologic factors - therapeutic use (4013) 4013
treatment outcome (3513) 3513
immunotherapy (3214) 3214
aged (3036) 3036
mice (2924) 2924
research (2607) 2607
immunologic factors - adverse effects (2429) 2429
health aspects (2362) 2362
care and treatment (2330) 2330
oncology (2308) 2308
cancer (2202) 2202
risk factors (2191) 2191
adolescent (2088) 2088
immunologic diseases. allergy (2043) 2043
allergy (2036) 2036
analysis (1892) 1892
therapy (1823) 1823
research article (1787) 1787
child (1760) 1760
lymphocytes (1751) 1751
inflammation (1742) 1742
time factors (1696) 1696
cytokines (1681) 1681
immune system (1651) 1651
vaccines (1651) 1651
antigens (1647) 1647
medicine (1613) 1613
proteins (1593) 1593
immune response (1512) 1512
patients (1498) 1498
young adult (1488) 1488
immunologic factors - administration & dosage (1467) 1467
drug therapy (1466) 1466
clinical trials (1419) 1419
review (1396) 1396
transplantation (1379) 1379
t cells (1366) 1366
double-blind (1357) 1357
hematology (1354) 1354
medicine, research & experimental (1352) 1352
pharmacology & pharmacy (1347) 1347
children (1342) 1342
lymphocytes t (1333) 1333
disease (1298) 1298
dendritic cells (1292) 1292
safety (1292) 1292
infectious diseases (1271) 1271
medicine & public health (1266) 1266
medical research (1255) 1255
rituximab (1247) 1247
studies (1246) 1246
adjuvants, immunologic - administration & dosage (1222) 1222
antibodies (1216) 1216
retrospective studies (1192) 1192
expression (1191) 1191
vaccination (1181) 1181
infections (1170) 1170
multidisciplinary sciences (1167) 1167
antibodies, monoclonal - therapeutic use (1136) 1136
immunological tolerance (1106) 1106
allergy and immunology (1103) 1103
biology (1070) 1070
chemotherapy (1063) 1063
efficacy (1044) 1044
child, preschool (1041) 1041
science (1035) 1035
adjuvants, immunologic - therapeutic use (1024) 1024
physiological aspects (1018) 1018
asthma (1009) 1009
immunity (1009) 1009
immunoglobulins (1008) 1008
abridged index medicus (978) 978
surgery (953) 953
infection (952) 952
aged, 80 and over (947) 947
multiple sclerosis (943) 943
tumors (943) 943
clinical neurology (926) 926
t-lymphocytes - immunology (926) 926
internal medicine (917) 917
immunologic factors - pharmacology (916) 916
diagnosis (914) 914
immunization (912) 912
t-cells (898) 898
gene expression (890) 890
microbiology (882) 882
apoptosis (878) 878
cell biology (877) 877
adjuvants, immunologic - adverse effects (870) 870
disease models, animal (865) 865
clinical trials as topic (864) 864
dermatology (856) 856
follow-up studies (849) 849
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21614) 21614
German (155) 155
Russian (149) 149
French (132) 132
Japanese (94) 94
Spanish (85) 85
Italian (35) 35
Polish (25) 25
Chinese (21) 21
Danish (19) 19
Hungarian (12) 12
Portuguese (10) 10
Hebrew (6) 6
Czech (5) 5
Dutch (4) 4
Finnish (4) 4
Korean (3) 3
Swedish (3) 3
Norwegian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 8, pp. 1120 - 1129.e6
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2017, Volume 12, Issue 1, pp. 176 - 189
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 20, pp. 1921 - 1932
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 962 - 971
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2019, Volume 37, Issue 6, pp. 481 - 489
PURPOSE: Treatment options are limited for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Tumor cells can exploit the programmed... 
Hematopoietic Stem Cell Transplantation/adverse effects | Clinical Trial, Phase II | Humans | Middle Aged | Male | Journal Article | Research Support, N.I.H., Extramural | Young Adult | Time Factors | Treatment Failure | Aged, 80 and over | Adult | Female | Nivolumab/adverse effects | Chromosomes, Human, Pair 9 | Remission Induction | Disease Progression | Transplantation, Autologous/adverse effects | Lymphoma, Large B-Cell, Diffuse/drug therapy | Research Support, Non-U.S. Gov't | Progression-Free Survival | Multicenter Study | Aged | Programmed Cell Death 1 Receptor/antagonists & inhibitors | Antineoplastic Agents, Immunological/adverse effects | MULTICENTER | ONCOLOGY | PD-L1 | HODGKIN LYMPHOMA | OPEN-LABEL | OUTCOMES | DEATH LIGAND 1 | BLOCKADE | EXPRESSION | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, Large B-Cell, Diffuse - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Nivolumab - therapeutic use | Nivolumab - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Immunological - therapeutic use | Transplantation, Autologous - adverse effects | Programmed Cell Death 1 Receptor - immunology | Lymphoma, Large B-Cell, Diffuse - genetics | ORIGINAL REPORTS
Journal Article
Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 11/2002, Volume 91, Issue 11, pp. 988 - 998
... of multicenter clinical trials that used “targeted” approaches to neutralize tumor necrosis factor in patients with moderate to advanced heart failure... 
Clinical trial | Inflammatory mediators | Etanercept | Infliximab | Tumor necrosis factor | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | etanercept | infliximab | CYTOKINE LEVELS | FACTOR-ALPHA | inflammatory mediators | TUMOR-NECROSIS-FACTOR | CONVERTING ENZYME-INHIBITION | tumor necrosis factor | LEFT-VENTRICULAR DYSFUNCTION | EJECTION FRACTION | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | ADULT FELINE MYOCARDIUM | TNF-ALPHA | HEMATOLOGY | TRANSGENIC MICE | Tumor Necrosis Factor-alpha - metabolism | Humans | Antibodies, Monoclonal - adverse effects | Heart Failure - physiopathology | Antibodies, Monoclonal - therapeutic use | Endothelium, Vascular - drug effects | Pentoxifylline - adverse effects | Pentoxifylline - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Inflammation Mediators - pharmacology | Treatment Failure | Inflammation Mediators - metabolism | Antirheumatic Agents - adverse effects | Inflammation Mediators - antagonists & inhibitors | Heart Failure - etiology | Antirheumatic Agents - therapeutic use | Thalidomide - adverse effects | Cytokines - metabolism | Ventricular Function, Left - drug effects | Endothelium, Vascular - physiopathology | Immunoglobulin G - therapeutic use | Ventricular Dysfunction, Left - etiology | Clinical Trials as Topic | Disease Progression | Ventricular Dysfunction, Left - physiopathology | Heart Failure - drug therapy | Immunoglobulin G - adverse effects | Research - trends | Animals | Immunologic Factors - adverse effects | Cytokines - antagonists & inhibitors | Thalidomide - therapeutic use | Cytokines - pharmacology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Immunologic Factors - therapeutic use
Journal Article